1. Home
  2. ASPN vs EYPT Comparison

ASPN vs EYPT Comparison

Compare ASPN & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

N/A

Current Price

$4.91

Market Cap

407.5M

ML Signal

N/A

EYPT

EyePoint Pharmaceuticals Inc.

N/A

Current Price

$4.23

Market Cap

419.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ASPN
EYPT
Founded
2001
1987
Country
United States
United States
Employees
854
N/A
Industry
RETAIL: Building Materials
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
419.9M
IPO Year
2011
2005

Fundamental Metrics

Financial Performance
Metric
ASPN
EYPT
Price
$4.91
$4.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$4.25
$31.80
AVG Volume (30 Days)
744.9K
6.5M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$271,103,000.00
$7,539,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$50.03
$3,115.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$3.95
52 Week High
$9.35
$19.11

Technical Indicators

Market Signals
Indicator
ASPN
EYPT
Relative Strength Index (RSI) 39.74 28.63
Support Level $2.99 $3.95
Resistance Level $5.48 $18.99
Average True Range (ATR) 0.20 0.33
MACD -0.04 0.13
Stochastic Oscillator 6.66 11.43

Price Performance

Historical Comparison
ASPN
EYPT

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: